Alternatives
Stock screener alternatives
for European investors.
Most screeners are built for US equities. For European markets — BME, XETRA, Euronext, Borsa Italiana — the data is incomplete, the exchanges are missing, and the small caps are invisible. These pages compare the most popular tools honestly and explain where ScreenerHero fits.
Finviz alternatives
The best Finviz alternatives for European stocks
Finviz is the best-designed screener for US equities. For European markets, the data is incomplete and the exchanges are missing. These are the real alternatives.
Simply Wall St alternatives
Outgrown Simply Wall St? Here's what serious investors use instead
Simply Wall St is excellent for learning — but it's designed for browsing one stock at a time. When your strategy needs real filter-driven screening, you need a different tool.
TradingView alternatives
TradingView is built for charts. These are the screening alternatives.
TradingView's screener is a secondary feature — fundamental coverage for European small caps is inconsistent and filter combinations are gated. If screening drives your workflow more than charting, here's what to use instead.
Stockopedia alternatives
Stockopedia charges €60–80/mo for Europe only. Here are the alternatives.
Stockopedia covers UK and parts of continental Europe with no US or Canadian equities — at €60/month for EU or €80/month to add US. These alternatives give you more coverage for less.
Koyfin alternatives
Koyfin costs $39/mo. If you screen more than you chart, there's a better fit.
Koyfin Plus is an excellent charting platform — but it's charting-first. If 80% of your time is in the screener, you're paying $39/month for features you rarely use. These alternatives are built screening-first.
TIKR alternatives
TIKR covers 100k stocks — but European microcaps are a blind spot
TIKR has broad global coverage, but European microcaps and illiquid names are missing or incomplete. TIKR Pro runs $40–55/month. If you need full European depth, here's what actually covers it.
MarketScreener alternatives
MarketScreener is a news aggregator. Here's what a real screener looks like.
MarketScreener leads with analyst reports and news — the screener is bolted on. At $30–34/month you get a news subscription with filters, not a decision-oriented screening tool. These alternatives are built the other way around.
Stock Rover alternatives
Stock Rover goes deep on US and Canada — but stops at the Atlantic
Stock Rover has 700+ fundamental metrics for US and Canadian equities at $28/month. European exchanges are simply not covered. These are the alternatives for investors who need both sides of the ocean.
Barchart alternatives
Barchart is built for options traders. Here's what equity screeners look like.
Barchart Premier excels at US options, futures, and technical data. Fundamental coverage for European equities is thin and the exchanges aren't a focus. These are the alternatives for fundamental-first screening across global markets.
StockAnalysis alternatives
StockAnalysis is excellent for reading financials — not for filter-driven screening
StockAnalysis.com is one of the best free tools for browsing a company's income statement. But it is not a screener — you cannot filter by P/E, ROE, and margins simultaneously across European markets. Here is what filter-driven screening looks like.
Investing.com alternatives
Investing.com is a news portal. Its screener is buried and limited.
Investing.com has massive reach as a macro and news site. Its stock screener is a secondary feature — fundamental data for European small caps is unreliable and filter depth is limited. These are the alternatives built around screening first.
Morningstar alternatives
Morningstar is built for US research. European screening is an afterthought.
Morningstar Investor is trusted for its analyst ratings and US equity research — but European small cap coverage is thin and the screener is secondary to the report-browsing workflow. At $34.95/month, these alternatives give you more filter depth for less.
GuruFocus alternatives
GuruFocus goes deep on US value metrics. European coverage is thin.
GuruFocus is excellent for deep value research on US names — DCF, GF Value, 30-year financials. European equity screening is limited and it costs $449/year. These alternatives cover US and Europe at a lower price point.
Try ScreenerHero free — no account needed
Screen US, Canadian, and European stocks by P/E, ROE, EV/EBITDA, dividend yield, and more. Free core screener. No signup required.
Open the screener